Application 014763

Type
NDA
Sponsor
ASTRAZENECA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
003CITANESTPRILOCAINE HYDROCHLORIDEINJECTABLE;INJECTION3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004CITANESTPRILOCAINE HYDROCHLORIDEINJECTABLE;INJECTION1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005CITANESTPRILOCAINE HYDROCHLORIDEINJECTABLE;INJECTION2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
007CITANEST PLAINPRILOCAINE HYDROCHLORIDEINJECTABLE;INJECTION4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
008CITANEST FORTEEPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDEINJECTABLE;INJECTION0.005MG/ML;4%NoNo